Costs and resource use of community-dwelling patients with Alzheimer's disease in Japan: 18-month results from the GERAS-J study.
Miharu NakanishiAtaru IgarashiKaname UedaAlan J M BrnabicTaka MatsumuraKenichi MeguroMasahito YamadaMasaru MimuraHeii AraiTamas TreuerPublished in: Current medical research and opinion (2021)
Total treatment costs increased with AD severity over 18 months due to increases in both patient social care costs and caregiver informal care costs. Our data suggest current social care services in Japan are insufficient to alleviate the negative impact of AD on caregiver burden.